A patient is taking methadone as part of a heroin withdrawal program. The nurse understands that in this instance methadone is classified as which drug schedule?
C-V
C-II
C-I
C-III
The Correct Answer is B
A. C-V drugs are considered to have the lowest potential for abuse and are typically used for medications like cough preparations with less than 200 milligrams of codeine per 100 milliliters or per 100 grams. Methadone is not classified under C-V.
B. Methadone is classified as a C-II (Schedule II) controlled substance because it has a high potential for abuse, but it also has accepted medical uses, such as for opioid withdrawal management.
C. C-I drugs are considered to have no accepted medical use and a high potential for abuse (e.g., heroin, LSD). Methadone is not classified as a C-I drug.
D. C-III drugs have a moderate potential for abuse and are generally used for medications like anabolic steroids or some barbiturates, but methadone is not classified under C-III.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A. The ages and relationships of household members are subjective data because they are reported by the patient and not directly measured or observed.
B. Usual dietary patterns and intake are also subjective data, as they rely on patient self-reporting rather than measurable, verifiable findings.
C. A list of herbal supplements regularly used is subjective because it depends on the patient’s recall and self-reporting rather than objective measurement.
D. Lab values are considered objective data because they are measurable, verifiable, and obtained through diagnostic testing rather than patient self-reporting. Objective data are based on observable and quantifiable factors, making them more reliable for clinical decision-making.
Correct Answer is C
Explanation
A. Phase I trials focus on healthy individuals, but the next phase (Phase II) involves patients with the target disease. Including both healthy and ill subjects at this stage is not appropriate.
B. Subjects with other diseases are not included in Phase II trials because the goal is to test the drug in individuals who have the specific condition the drug is intended to treat.
C. Phase II clinical trials focus on evaluating the drug’s efficacy and safety in individuals who have the disease it is designed to treat. This phase helps determine the optimal dosage and potential side effects in the target population.
D. Healthy subjects are included in Phase I trials to assess safety and pharmacokinetics, but in the next phase (Phase II), the study shifts to testing the drug in patients with the disease it is meant to treat.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.